Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Blyth

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Plos One|August 29, 2020
Tracking down carbon inputs underground from an arid zone Australian calcreteMattia Saccò, Alison J Blyth, William F Humphreys, et al.
BMJ Open|June 9, 2023
Robotic Arthroplasty Clinical and cost Effectiveness Randomised controlled trial (RACER-knee): a study protocolJames Griffin, Edward T Davis, Helen Parsons, et al.
Cancer Discovery|August 7, 2023
Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor ImmunityAndrew A Guirguis, Yaara Ofir-Rosenfeld, Kathy Knezevic, et al.
Cancer Discovery|June 19, 2025
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemiaShellaina J V Gordon, Florian Perner, Laura MacPherson, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Plos One|August 29, 2020
Tracking down carbon inputs underground from an arid zone Australian calcreteMattia Saccò, Alison J Blyth, William F Humphreys, et al.
BMJ Open|June 9, 2023
Robotic Arthroplasty Clinical and cost Effectiveness Randomised controlled trial (RACER-knee): a study protocolJames Griffin, Edward T Davis, Helen Parsons, et al.
Cancer Discovery|August 7, 2023
Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor ImmunityAndrew A Guirguis, Yaara Ofir-Rosenfeld, Kathy Knezevic, et al.
Cancer Discovery|June 19, 2025
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemiaShellaina J V Gordon, Florian Perner, Laura MacPherson, et al.
Pageof 8